Shi, Y., Duan, Y., Ji, Y., Wang, Z., Wu, Y., Gunosewoyo, H., . . . Yu, L. (2017). Amidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis. American Chemical Society.
Chicago Style (17th ed.) CitationShi, Y., et al. Amidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis. American Chemical Society, 2017.
MLA (9th ed.) CitationShi, Y., et al. Amidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis. American Chemical Society, 2017.
Warning: These citations may not always be 100% accurate.